The authors demonstrated the clinical utility of the Prosigna assay to aid decision - making in relation to
the use of adjuvant chemotherapy for both node - negative and node - positive disease.
Not exact matches
These studies will investigate whether Src kinase inhibitors are best
used in the
adjuvant setting post-surgery or after
chemotherapy to prevent the formation
of local and distant disease recurrence.
Progress in prevention and early detection, and the
use of chemotherapy after surgery (
adjuvant chemotherapy), have achieved significantly increase survival in this disease in the last ten years, but much remains to be done.